The Biology Of Cancer Robert A. Weinberg

0 views

Skip to first unread message

Victorino Eagle

unread,

Aug 5, 2024, 10:52:28 AM8/5/24

to natilkeida

TheBiology of Cancer is a textbook for students studying the molecular and cellular bases of cancer at the undergraduate, graduate, and medical school levels. The principles of cancer biology are presented in an organized, cogent, and in-depth manner. The clarity of writing, supported by an extensive full-color art program and numerous pedagogical features, makes the book accessible and engaging. The information unfolds through the presentation of key experiments that give readers a sense of discovery and provide insights into the conceptual foundation underlying modern cancer biology.

Every copy of the book comes with an updated "Pathways in Human Cancer" poster and a DVD-ROM containing the book's art program, a greatly expanded selection of movies, audio file mini-lectures, Supplementary Sidebars, and a Media Guide.

"The book fulfills its purpose and is, indeed, a must-read for students of cancer biology...It includes updated information and concepts in cancer research that justify replacing the previous edition."

- Doody Reviews

"This publication represents an exhaustive and detailed coverage of the field of basic oncology oriented toward a student audience, and it continues to set the highest example of excellence in the field of undergraduate and graduate oncology." - The Quarterly Review of Biology

"Clearly, not only is it an authoritative text book on the complex biology of cancer, it serves as an invaluable reference document for individuals working in biomedical laboratories as well as professionals involved in day to day management of cancer in the clinics." - Oncology News

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

These approaches served us well over the past half-century: witness the revolutions in molecular and cellular biology, immunology, neurobiology and genetics. Our insights into pathogenetic mechanisms exceed the wildest speculations of 50 years ago.

Now the dominant position of hypothesis-driven research is under threat. Many feel that traditional conceptual tools cannot map the enormous complexity that allows single cells and complex organisms to thrive, and that recent technological innovations have created a viable alternative. My students can gather certain types of experimental data 1,000 and even 10,000 times faster than I could 40 years ago.

Large-scale efforts such as the Human Genome Project are portrayed as the future, and as central to the discipline of systems biology that has since emerged. Increasing proportions of national research budgets are being diverted to them. But is it worth extinguishing 20 or 30 small-scale, hypothesis-driven projects to make room for an attack at the systems-wide level?

From a cancer researcher's perspective, the successes of hypothesis-driven science are clear and undeniable. They stretch back over half a century and continue week after week, month after month, to yield new conceptual insights. By contrast, the new ways of doing biology are so untested that their long-term benefits are still hard to project. Nonetheless, it's useful to make comparisons, if only because economic necessities force them to be made.

Analysis of expression arrays, which show which genes are active in a tumour sample, have shown that cancers previously viewed as a single entity have different pathogenetic mechanisms and respond differently to therapy. The use of genome-wide libraries of small interfering RNAs to inhibit large cohorts of genes, and so identify those behind cancer, is a blend of the old and the new. It lacks a clear preconception of what will eventually be found, but contains clear hypotheses about the biological phenotypes that will result. This approach, still in its infancy, has been remarkably productive.

Sequencing of entire tumour genomes (or their coding exons) has a more mixed record. These projects consume an enormous amount of resources and researchers' energy. The dividends to date have been modest: the discovery of several new oncogenes and tumour suppressor genes involved in tumour formation (for example, BRAF, IDH1/2 and translocations in prostate carcinomas), and a general measure of the degree of genetic instability of various tumour-cell genomes.

We use cookies and similar tools that are necessary to enable you to make purchases, to enhance your shopping experiences and to provide our services, as detailed in our Cookie notice. We also use these cookies to understand how customers use our services (for example, by measuring site visits) so we can make improvements.

If you agree, we'll also use cookies to complement your shopping experience across the Amazon stores as described in our Cookie notice. Your choice applies to using first-party and third-party advertising cookies on this service. Cookies store or access standard device information such as a unique identifier. The 103 third parties who use cookies on this service do so for their purposes of displaying and measuring personalized ads, generating audience insights, and developing and improving products. Click "Decline" to reject, or "Customise" to make more detailed advertising choices, or learn more. You can change your choices at any time by visiting Cookie preferences, as described in the Cookie notice. To learn more about how and for what purposes Amazon uses personal information (such as Amazon Store order history), please visit our Privacy notice.

Thoroughly updated and incorporating the most important advances in the fast-growing field of cancer biology, The Biology of Cancer, Second Edition, maintains all of its hallmark features admired by students, instructors, researchers, and clinicians around the world.

This landmark review soon became an essential resource for cancer researchers, with tens of thousands of citations, providing a comprehensive foundation for understanding and studying cancer biology. To account for new discoveries and progress in the field, the authors provided a first update in 2011, adding two emerging hallmarks and a new enabling characteristic.

Weinberg and Hanahan described the six capabilities acquired by cancer cells as the successful breaching of just as many anticancer defense mechanisms wired into our cells, and suggested these characteristics were shared by the more than 100 distinct types of cancer known at the time. Thus, the hallmarks of cancer provided a few unifying concepts toward which future cancer research could gravitate.

In 2011, Weinberg and Hanahan published an update discussing the progress made over the preceding decade in the knowledge about the six original hallmarks. They also incorporated two emerging hallmarks:

The 2011 edition also identified tumor-promoting inflammation as a new enabling characteristic. While immune infiltrates were historically considered a sign of the immune system reacting against the tumor, at the time the second review was published, the tumor-promoting effect of certain inflammatory cells had become clear. The authors discussed how inflammation favors multiple hallmark capabilities by providing growth, survival, and proangiogenic factors, and releasing chemicals, such as reactive oxygen species, that can cause additional mutations in the nearby cancer cells.

The review also contains a paragraph on the tumor microenvironment, which in the previous decade had become the subject of extensive research showing that, when studying the biology of a tumor, one needs to consider both the cancer cells and the microenvironment they construct around them.

The new edition acknowledged the importance of senescent cells as instrumental components of the tumor microenvironment. While in the 2000 edition the authors discussed senescence as a possible anticancer barrier, they did not rule out the possibility of it being an artifact of cell culture that did not represent a real cell phenotype in vivo. More than two decades later, the role of cellular senescence in tissue homeostasis and cancer is well recognized, and significant morphological and metabolic features associated with it have been uncovered. Research has also shown how, in certain contexts, senescent cells can stimulate tumor development and malignant progression. Therefore, Hanahan proposed that senescent cells should be included as significant components of the tumor microenvironment.

Cancers are a complicated disease that causes rapid multiplication and growth of specific cells of the body. It can lead to cancer or neoplasm, an unusual mass of tissues.

Oncology is a medical discipline dealing with the diagnosis and management of cancer. If left untreated, it can progress into serious conditions endangering the life of the patients. Understanding disease at the cellular level can upgrade. The accuracy of disease diagnosis, management, and prevention of cancers. Additionally, a solid understanding of cancer with the assistance of disease tests from patients encourages clinical interpretations to forestall, treat and alleviate disease and related intricacies.